Status:
UNKNOWN
Parametric Mapping in Paediatric Magnetic Resonance Imaging
Lead Sponsor:
Hong Kong Children's Hospital
Conditions:
Cardiac Disease
Pediatric Disease
Eligibility:
All Genders
Up to 18 years
Brief Summary
Magnetic resonance imaging (MRI) is increasingly an important tool for diagnosis and management of cardiac diseases in children. One of the uses of MRI is tissue characterisation, in which the signal...
Detailed Description
Magnetic resonance Imaging (MRI) can provide tissue characterisation without radiation and need for invasive biopsy. Parametric mapping techniques (T1 mapping, extracellular volume fraction, T2 mappi...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Paediatric patients \<=18 years of age with suspected or confirmed cardiac disease undergoing clinically indicated MRI
Exclusion
- Unstable or uncooperative patients that cannot tolerate MRI
- Patients with contraindications for MRI (e.g. patients with implanted devices that are not MRI compatible)
Key Trial Info
Start Date :
August 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04068987
Start Date
August 23 2019
End Date
December 1 2022
Last Update
February 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiology, Hong Kong Children's Hospital
Hong Kong, Hong Kong, 00000